ProPhase Labs, Inc. (PRPH) NASDAQ

0.15

-0.0005(-0.33%)

Updated at February 13 03:15PM

Currency In USD

Valuation

Market Cap14.44M
Enterprise Value38.34M
P/E Ratio-0.02
PEG Ratio-0
Price/Sales Ratio0.67
Price/Book Ratio0.09
Enterprise/Revenue7.43
Enterprise/EBITDA-0.32

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-38.72
Operating Margin-24.97

Management Effectiveness

Return On Assets-0.63
Return On Equity-4.04

Income Statement

Revenue6.77M
Revenue/Share0.26
Gross Profit-150,000
EBITDA-32.34M
Net Income-53.36M
Diluted EPS-26.1

Balance Sheet

Total Cash405,000
Total Cash/Share0.1
Total Debt7.68M
Total Debt/Equity1.12
Current Ratio0.14
Book Value Per Share1.65

Price History

52-Week Change-95.5
52-Week High7.8
52-Week Low0.12
Moving Average 50 Days0.55
Moving Average 200 Days2.91

Statistics

Average Volume1.19M
Shares Outstanding4.74M
% Held by Institutions7.18

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateDecember 22, 2025